[HTML][HTML] Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment

H Tian, J Cao, B Li, EC Nice, H Mao, Y Zhang… - Bone Research, 2023 - nature.com
Osteosarcoma, with poor survival after metastasis, is considered the most common primary
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment

H Tian, J Cao, B Li, EC Nice, H Mao… - Bone …, 2023 - pubmed.ncbi.nlm.nih.gov
Osteosarcoma, with poor survival after metastasis, is considered the most common primary
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment.

H Tian, J Cao, B Li, EC Nice, H Mao, Y Zhang… - Bone …, 2023 - search.ebscohost.com
Osteosarcoma, with poor survival after metastasis, is considered the most common primary
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment

H Tian, J Cao, B Li, EC Nice, H Mao, Y Zhang… - Bone …, 2023 - search.proquest.com
Osteosarcoma, with poor survival after metastasis, is considered the most common primary
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment.

H Tian, J Cao, B Li, EC Nice, H Mao, Y Zhang… - Bone …, 2023 - europepmc.org
Osteosarcoma, with poor survival after metastasis, is considered the most common primary
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …

[HTML][HTML] Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment

H Tian, J Cao, B Li, EC Nice, H Mao, Y Zhang… - Bone …, 2023 - ncbi.nlm.nih.gov
Osteosarcoma, with poor survival after metastasis, is considered the most common primary
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment.

H Tian, J Cao, B Li, EC Nice, H Mao, Y Zhang… - Bone …, 2023 - europepmc.org
Osteosarcoma, with poor survival after metastasis, is considered the most common primary
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …